Stay updated with breaking news from John Eng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While other drugs discovered in recent decades for diseases like cancer, heart disease and Alzheimer’s were found through a logical process that led to clear targets for drug designers, the path that led to the obesity drugs was not like that. In fact, much about the drugs remains shrouded in mystery.
Every so often a drug comes along that has the potential to change the world. Medical specialists say the latest to offer that possibility are the new drugs that treat obesity — Ozempic, Wegovy, Mounjaro and more that may soon be coming onto the market. It’s early, but nothing like these drugs has existed before. “Game changers,” said Jonathan Engel, a historian of medicine and health care policy at Baruch College in New York. Sign up for The Morning newsletter from the New York Times Obesity af
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/UESDJCOJ5ZG75OYNWS53GKWQME.jpg)
NY Times: Drug makers 'got lucky', experts say - and there's still a lot they don't know.
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.